<DOC>
	<DOCNO>NCT01271452</DOCNO>
	<brief_summary>This study evaluate safety efficacy two different type botulinum toxin type A treatment glabellar frown line .</brief_summary>
	<brief_title>Safety Efficacy Two Types Botulinum Toxin Type A For Treatment Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe glabellar frown line Diagnosis myasthenia gravis Eaton Lambert syndrome Aesthetic treatment botulinum toxin within 6 month plan treatment botulinum toxin reason study Prior filler treatment , surgery , insertion procedure in/to glabellar region Facial cosmetic procedure glabellar area within 6 month Bleeding disorder use anticoagulant within 10 day History facial nerve palsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>